MDM2 Polyclonal Antibody

MDM2 Polyclonal Antibody

The MDM2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of MDM2 protein expression in various biological samples. With a size of 200μL, this antibody is provided in a concentrated form, with a concentration of 1 mg/mL, ensuring optimal performance and cost-effectiveness.

MDM2, also known as Mouse Double Minute 2 homolog, is a critical regulator of the p53 tumor suppressor pathway. It plays a crucial role in the degradation of p53, thereby inhibiting its tumor suppressive functions. Dysregulation of MDM2 has been implicated in various human cancers, making it an important target for research and therapeutic interventions.

This polyclonal antibody has been meticulously developed using advanced immunization techniques, resulting in a high affinity and specificity towards MDM2 protein. It has been extensively validated for its performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The MDM2 Polyclonal Antibody offers several advantages over other commercially available antibodies. Its high sensitivity allows for the detection of low levels of MDM2 protein, enabling researchers to accurately quantify its expression in different samples. Additionally, its polyclonal nature ensures recognition of multiple epitopes on the target protein, enhancing the reliability and reproducibility of experimental results.

Furthermore, this antibody has been rigorously tested for cross-reactivity with other proteins to ensure specificity. It exhibits minimal background noise, enabling clear and precise visualization of MDM2 protein bands or localization in tissues.

In summary, the MDM2 Polyclonal Antibody is a valuable tool for researchers studying the role of MDM2 in cancer biology. Its high sensitivity, specificity, and versatility make it an ideal choice for a wide range of applications, facilitating accurate and reliable analysis of MDM2 protein expression.